We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Silence Therapeutics Plc | LSE:SLN | London | Ordinary Share | GB00B9GTXM62 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 535.00 | 521.00 | 524.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/10/2012 12:27 | Wonder if we will see an afternoon US surge.....? | gowboy | |
04/10/2012 11:33 | I sold out this morning at 2.9p for a nice profit with a heavy heart. I had a sizeable holding that took a while to sell,and all the time the price held,which suggests that somebody is hoovering up loose stock. GLA......Geoff. | geoffmanana | |
04/10/2012 10:54 | Poor sods that listened to him last week. | sos100 | |
04/10/2012 08:56 | De-ramping SLN was one thing but ramping other shares on this board is getting too much: buywell2 filtered. | aquilla | |
04/10/2012 08:43 | Price is being driven by at least one new stakebuilder IMO. I am expecting 3.1 today. Wishful thinking? Maybe but it would be a nice. Onwards & upwards. | billthebank | |
04/10/2012 08:31 | Something is driving this lately... | gerri-c | |
04/10/2012 08:30 | Are we going to make 3p today mmmmmm! Good volume. | billynotsilly | |
03/10/2012 17:14 | Massive announcement from Sarepta,the US RNAi company,stock price up more than 100% today adding $500m to market cap on promising drug results.Imagine if that could be one of Silences like 027 that rise would be 20p on Silence share price!!Thats a bit of upside. | amiright | |
03/10/2012 16:50 | Thanks for the link lucky_punter. Very interesting article. I like this bit: "Via Quark it has four of these arm's length relationships with Pfizer and Novartis worth a potential US$170 million." The rewards could be huge if things work out. | aquilla | |
03/10/2012 15:49 | Shares in Silence Therapeutics (LON:SLN) jumped 11 per cent in afternoon trade after an American company working in the same technology field notched a stunning clinical success. | lucky_punter | |
03/10/2012 15:41 | Any news expected here? | hjfe | |
03/10/2012 14:52 | Hi cc how are you doing feller? | geoffmanana | |
03/10/2012 14:49 | PROBABLY AN RNS ON DRUG TRIALS COMING OUT. | chicken charlie | |
03/10/2012 14:29 | Looks good, has it been tipped somewhere Shame charts don't seem to be working | sos100 | |
03/10/2012 14:28 | .....and again. | geoffmanana | |
03/10/2012 13:49 | Nice rise. | geoffmanana | |
02/10/2012 00:56 | It has also popped up on thisismoney - nice to be getting some coverage! | frndlyfire | |
01/10/2012 10:49 | Quoted in the recent interim results statement, Silence Therapeutics (LON:SLN) director Ali Mortazavi was brutally honest when he admitted it had been a difficult six months for the biotech and its staff. A change of senior management and the write-down of the value of the key investment has drawn a line in the sand with the past. | lucky_punter | |
29/9/2012 12:35 | A link to the proactive investor article: | gerri-c | |
29/9/2012 08:46 | A link to the proactive investors article: | gerri-c | |
28/9/2012 22:49 | Probably was Buywell, I understand he has talent scouts (like football clubs do)scouring the Bulletin Boards for glimpses of Genius and Tips to act on. credit where its due.Well done! | algernon2 | |
28/9/2012 18:08 | So Richard 'the Lionheart' Griffiths now also owns 4.3% of Source Bioscience (SBS) as well as 29% of SLN Was it something I said ? | buywell2 | |
28/9/2012 16:50 | Welcome back! | algernon2 | |
28/9/2012 15:53 | im back in again. gla | mrsapeslaptop |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions